Based on the postsurgical specimens with long-term follow-up data, we demonstrated the prognostic relevance of the two major immunosuppressive components, MDSCs and the PD-1/PD-L1 immune checkpoint, in the tumor microenvironment. The gene discussed is CD274; the disease is neoplasm.